Details for New Drug Application (NDA): 200823
✉ Email this page to a colleague
The generic ingredient in PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE is metformin hydrochloride; pioglitazone hydrochloride. There are forty-nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the metformin hydrochloride; pioglitazone hydrochloride profile page.
Summary for 200823
| Tradename: | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE |
| Applicant: | Aurobindo Pharma Ltd |
| Ingredient: | metformin hydrochloride; pioglitazone hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 200823
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | metformin hydrochloride; pioglitazone hydrochloride | TABLET;ORAL | 200823 | ANDA | Rising Pharma Holdings, Inc. | 57237-217 | 57237-217-60 | 60 TABLET, FILM COATED in 1 BOTTLE (57237-217-60) |
| PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | metformin hydrochloride; pioglitazone hydrochloride | TABLET;ORAL | 200823 | ANDA | Rising Pharma Holdings, Inc. | 57237-217 | 57237-217-81 | 180 TABLET, FILM COATED in 1 BOTTLE (57237-217-81) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG;EQ 15MG BASE | ||||
| Approval Date: | Feb 13, 2013 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 850MG;EQ 15MG BASE | ||||
| Approval Date: | Feb 13, 2013 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
